结论磺达肝癸钠治疗非st段抬高急性冠脉综合征安全有效。
ConclusionFondaparinux Na was a safe and effective treatment for NSTEMI.
非st段抬高急性冠脉综合征患者BNP水平也增高，表明BNP水平与缺血的范围以及严重程度有关联。
BNP is also increased during non-ST elevation acute coronary syndrome, indicating that BNP level may be associated with the scope of ischemia and the severity of disease.
目的比较2000年和2006年非st段抬高急性冠脉综合征患者的诊疗策略变化，比较与指南的差距。
Objective To compare the diagnosis and management of patients with Non_ST elevation acute coronary syndrome between 2000 and 2006, scale the gap between practice and guidelines.
目的：本研究旨在探讨90岁以上非st段抬高急性冠脉综合征(NSTE - ACS)患者的治疗措施及预后。
Objectives: the goal of this work was to explore the treatment and outcomes of patients with non-st-segment elevation acute coronary syndromes (NSTE-ACS) age 90 years.
背景合并2型糖尿病的非st段抬高的急性冠脉综合征病人，无论用当前任何治疗方法，都有较高的大血管事件发生率。
Background Despite current treatment, patients who have acute coronary syndromes without ST-segment elevation associated with t 2 Diabetes have high rates of major vascular events.
研究者检查了治疗实验中681名无st段抬高的急性冠脉综合征病人的GRACE危险分数。
The researchers determined the GRACE risk score in 681 non-ST-elevation ACS patients enrolled in a treatment trial.
目的：探讨血府逐瘀汤治疗非ST段抬高型急性冠脉综合征（NEST-ACS）的临床疗效及其对炎症因子的影响。
Objective:To investigate the Xuefu Zhuyu Tang(XZT) treatment of non-ST segment elevation Acute Coronary Syndrome(NEST-ACS) and its impact on the effects of Inflammatory factors.
急性冠脉综合征(ACS)包括不稳定心绞痛(UA)、非st段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)。
Acute coronary syndrome (ACS) includes unstable angina (UA), non-ST segment elevated myocardial infarction (NSTEMI) and st segment elevated myocardial infarction (STEMI).
急性冠脉综合征(ACS)包括不稳定心绞痛(UA)、非st段抬高心肌梗死(NSTEMI)和ST段抬高心肌梗死(STEMI)。
Acute coronary syndrome (ACS) includes unstable angina (UA), non-ST segment elevated myocardial infarction (NSTEMI) and st segment elevated myocardial infarction (STEMI).
应用推荐